PL94965B1 - - Google Patents

Download PDF

Info

Publication number
PL94965B1
PL94965B1 PL1974175278A PL17527874A PL94965B1 PL 94965 B1 PL94965 B1 PL 94965B1 PL 1974175278 A PL1974175278 A PL 1974175278A PL 17527874 A PL17527874 A PL 17527874A PL 94965 B1 PL94965 B1 PL 94965B1
Authority
PL
Poland
Prior art keywords
hydroxy
dibenzo
dimethyl
pyranone
tetrahydro
Prior art date
Application number
PL1974175278A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of PL94965B1 publication Critical patent/PL94965B1/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78Ring systems having three or more relevant rings
    • C07D311/80Dibenzopyrans; Hydrogenated dibenzopyrans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/747Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups containing six-membered aromatic rings

Claims (9)

1. Zastrzezenia patentowe 1. Sposób wytwarzania nowych pochodnych szesciowodorodwubenzo[b,d]piranonu-9 o wzorze 1, w którym Ri oznacza normalna grupe alkilowa o 7—10 atomach wegla lub grupe o wzorze 2, w którym R3 oznacza grupe alkilowa o 4—7 atomach wegla lub grupe alkenylowa o 4—7 atomach wegla, R4 oznacza atom wodoru lub grupe metylowa, a obydwa podstawniki R sa takie same i oznaczaja atomy wodoru lub grupy metylowe, znamienny t y m, ze czterowodorodwubenzo[b,d]piranon-9 o wzorze 3, w którym R i Rt maja wyzej podane znaczenie, redukuje sie metalem alkalicznym w cieklym amoniaku.
2. Sposób wedlug zastrz, 1,znamienny tym, ze w przypadku otrzymywania dl-trans-1-hydroksy-3- -/r,r-dwumetyloheptylo/-6,6a|3,7,8,10,10aa- szesciowodoro-6,6-dwumetylo-9H-dwubenzo[b,d]piranonu-9 redu¬ kuje sie dl-1-hydroksy- 3-/r,r-dwumetyloheptylo/6,6a,7,8-czterowodoro-6,6-dwumetylo-9H-dwubenzo[b,d]pira- non-9.
3. Sposób wedlug zastrz. 1, znamienny tym, ze w przypadku otrzymywania dl-cis-l-hydroksy-3- -/r,r-dwumetyloheptylo/-6,6aj3,7,8,10,l0aj3- szesciowodoro-6,6^dwumetylo-9H-dwubenzo [b,d]piranonu-9 redu¬ kuje sie dl-1-hydroksy-3- /r,r-dwumetyloheptylo/-6,6a,7,8-czterowodoro-6,6-deumetylo -9H-dwubenzo[b,d]pi- ranon-9.
4. Sposób wedlug zastrz. 1,znamienny tym, ze w przypadku otrzymywania dl-trans-l-hydroksy-3- -/1',2'-dwumetyloheptylo/-6,6aj3,7,8,10,1 Oaa- szesciowodoro-6,6-dwumetylo -9H-dwubenzo[b,d]piranonu-9 redu¬ kuje sie dM-hydroksy- 3-/r,2'-dwumetyloheptylo/-6,6a,7,8-czterowodoro-6,6-dwumetylo-9H-dwubenzo[b,d]pi- ranon-9.
5. Sposób wedlug zastrz* 1,znamienny tym, ze w przypadku otrzymywania dl-trans-1-hydroksy-3- -/n-h«ptylo/- 6,6a/J,7,8,10,10aa-szesciowodoro-6,6- dwumetylo-9H-dwubenzo[b,d]piranonu-9 redukuje sie dl;l-hydroksy-3-/n-heptylo/-6,6a,7,8-czterowodoro-6,6-dwumetylo-9H-dwubenzo[b,d]-piranon-9.
6. Sposób wedlug zastrz. 1, znamienny tym, ze w przypadku otrzymywania dl-trans-1-hydroksy-3- -/r-rnetyloheptylo/-6,6a0,7,8,lO,lOaa- szesciowodoro-6,6-dwumetylo-9H-dwubenzo[b,d]piranonu-9 redukuje sie dlil-hydroksy-3-/r-metyloheptylo/-6,6a,7,8-czterowodoro-6,6-dwumetylo-9H-dwubenzo[b,d]piranon-9.
7. Sposób wedlug zastrz, 1,znamienny tym, ze w przypadku otrzymywania dl-trans-1-hydroksy-3- -/r,r-dwumetylooktylo/- 6,6a/37,8,10,10aa- szesciowodoro-6,6-dwumetylo- 9H-dwubenzo[b,d]piranonu-9 redu¬ kuje sie dl-1-hydroksy- 3r/r,r-dwumetylooktylo/-6,6a,7,8-czterowodoro-6,6-dwumetylo -9H-dwubenzo[b,d]pi- ranon-9.
8. Sposób wedlug zastrz. 1,znamienny tym, ze w przypadku otrzymywania dl-trans-1-hydroksy-3- -/l\r-dwumetylopentylo/-6,6a0^ redu¬ kuje sie dl-1-hydroksy-3-/r,T- dwumetylopentylo/-6,6a,7,8-czterowodoro-6,6-dwumetylo -9H-dwubenzo[b,d]pi- ranon-
9.94 965 !«., OH Wzór 3 Prac. Poligraf. UP PRL naklad 120+18 Cena 10 zl PL PL PL PL
PL1974175278A 1973-11-05 1974-10-31 PL94965B1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US413009A US3928598A (en) 1973-11-05 1973-11-05 Hexahydro-dibenzo{8 b,d{9 pyran-9-ones as an anti-anxiety drug

Publications (1)

Publication Number Publication Date
PL94965B1 true PL94965B1 (pl) 1977-09-30

Family

ID=23635412

Family Applications (2)

Application Number Title Priority Date Filing Date
PL1974175278A PL94965B1 (pl) 1973-11-05 1974-10-31
PL1974193705A PL100502B1 (pl) 1973-11-05 1974-10-31 Sposob wytwarzania nowych pochodnych szesciowodorodwubenzo/b,d/piranonu-9

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL1974193705A PL100502B1 (pl) 1973-11-05 1974-10-31 Sposob wytwarzania nowych pochodnych szesciowodorodwubenzo/b,d/piranonu-9

Country Status (25)

Country Link
US (1) US3928598A (pl)
JP (1) JPS6033834B2 (pl)
AR (1) AR206409A1 (pl)
AT (1) AT337178B (pl)
BE (1) BE821719A (pl)
BG (1) BG25995A3 (pl)
CA (1) CA1029383A (pl)
CH (1) CH611290A5 (pl)
CS (1) CS193506B2 (pl)
DD (1) DD116229A5 (pl)
DE (1) DE2451932C2 (pl)
DK (1) DK136718B (pl)
ES (1) ES431675A1 (pl)
FR (1) FR2249663B1 (pl)
GB (1) GB1487636A (pl)
HU (1) HU169192B (pl)
IE (1) IE40025B1 (pl)
IL (1) IL45662A (pl)
NL (1) NL180979C (pl)
PH (1) PH10476A (pl)
PL (2) PL94965B1 (pl)
SE (1) SE415761B (pl)
SU (1) SU515457A3 (pl)
YU (1) YU36946B (pl)
ZA (1) ZA745794B (pl)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4051152A (en) * 1976-01-07 1977-09-27 Sharps Associates Oxo C-ring benzopyrans
US4087546A (en) * 1976-02-17 1978-05-02 Eli Lilly And Company Hexahydro-dibenzo[b,d]pyran-9-ones as antiasthmatic drugs
US4087545A (en) * 1976-02-17 1978-05-02 Eli Lilly And Company Hexahydro-dibenzo[b,d]pyran-9-ones as antiemetic drugs
SE7704749L (sv) * 1976-05-17 1977-12-05 Pfizer Kinoliner och forfarande och mellanprodukter for framstellning derav
US4054581A (en) * 1976-07-06 1977-10-18 Eli Lilly And Company Preparation of cis-1-hydroxy-3-substituted-6,6-dimethyl-6,6a,7,8,10,10a-hexahydro-9H-dibenzo[b,d]pyran-9-ones and intermediates therefor
US4102902A (en) * 1976-11-10 1978-07-25 Eli Lilly And Company Stereoselective preparation of hexahydro dibenzopyranones and intermediates therefor
US4351833A (en) * 1980-07-28 1982-09-28 Pfizer Inc. 9-Amino-1-hydroxyoctahydrobenzo[c]quinolines and derivatives thereof as analgesics and anti-emetics
US4309545A (en) * 1980-07-28 1982-01-05 Pfizer Inc. Oximino-1-hydroxyoctahydrobenzo[c]quinolines and derivatives thereof
US5498419A (en) * 1994-06-03 1996-03-12 Pars; Harry G. Fumarate salt of 4-(diethyl-3-(1-methyloctyl)-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran-1-ol, 4-(diethyl-amino) butyric
WO1999057106A1 (en) * 1998-05-04 1999-11-11 The University Of Connecticut Novel analgesic and immunomodulatory cannabinoids
US7897598B2 (en) * 1998-06-09 2011-03-01 Alexandros Makriyannis Inhibitors of the anandamide transporter
US7589220B2 (en) * 1998-06-09 2009-09-15 University Of Connecticut Inhibitors of the anandamide transporter
US7276613B1 (en) 1998-11-24 2007-10-02 University Of Connecticut Retro-anandamides, high affinity and stability cannabinoid receptor ligands
US7161016B1 (en) 1998-11-24 2007-01-09 University Of Connecticut Cannabimimetic lipid amides as useful medications
US6566560B2 (en) 1999-03-22 2003-05-20 Immugen Pharmaceuticals, Inc. Resorcinolic compounds
US6943266B1 (en) 1999-10-18 2005-09-13 University Of Connecticut Bicyclic cannabinoid agonists for the cannabinoid receptor
US7741365B2 (en) * 1999-10-18 2010-06-22 University Of Connecticut Peripheral cannabinoid receptor (CB2) selective ligands
US8084467B2 (en) * 1999-10-18 2011-12-27 University Of Connecticut Pyrazole derivatives as cannabinoid receptor antagonists
US7119108B1 (en) * 1999-10-18 2006-10-10 University Of Connecticut Pyrazole derivatives as cannabinoid receptor antagonists
US7393842B2 (en) * 2001-08-31 2008-07-01 University Of Connecticut Pyrazole analogs acting on cannabinoid receptors
WO2001028329A1 (en) 1999-10-18 2001-04-26 University Of Connecticut Peripheral cannabinoid receptor (cb2) selective ligands
US6900236B1 (en) 1999-10-18 2005-05-31 University Of Connecticut Cannabimimetic indole derivatives
AU2002213429A1 (en) * 2000-09-28 2002-04-08 Immugen Pharmaceuticals, Inc. Antiviral methods and compounds
AU2001296402A1 (en) * 2000-09-28 2002-04-08 Immugen Pharmaceuticals, Inc. Methods and compounds for inhibiting eicosanoid metabolism and platelet aggregation
EP1361876A4 (en) * 2001-01-26 2004-03-31 Univ Connecticut NEW CANNABIMIMETIC LIGANDS
CA2436133A1 (en) 2001-01-29 2002-08-08 University Of Connecticut Receptor selective cannabimimetic aminoalkylindoles
JP4312594B2 (ja) * 2001-07-13 2009-08-12 ユニバーシティ オブ コネチカット 新規な二環式及び三環式カンナビノイド
EP1448557A4 (en) * 2001-10-26 2005-02-02 Univ Connecticut HETEROINDANE: A NEW CLASS OF HIGH-ACTIVITY CANNABIMIMETIC LIGANDS
WO2003080043A1 (en) * 2002-03-18 2003-10-02 Immugen Pharmaceuticals, Inc. Topical formulations of resorcinols and cannibinoids and methods of use
EP1545502A4 (en) 2002-08-23 2008-12-24 Univ Connecticut KETO CANNABINOIDS WITH THERAPEUTIC INDICATIONS

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3507885A (en) * 1966-03-25 1970-04-21 Hoffmann La Roche 3-alkyl-6h-dibenzo(b,d)pyrans
US3636058A (en) * 1966-03-25 1972-01-18 Hoffmann La Roche 7 10 - dihydro - 3 - alkyl - 6h - dibenzo(b d) pyran-6 9(8h)-diones and 5-hydroxy-7-alkyl-4-chromanones

Also Published As

Publication number Publication date
IL45662A0 (en) 1974-11-29
FR2249663A1 (pl) 1975-05-30
YU36946B (en) 1984-08-31
ZA745794B (en) 1976-04-28
DK136718B (da) 1977-11-14
IE40025B1 (en) 1979-02-28
CA1029383A (en) 1978-04-11
AR206409A1 (es) 1976-07-23
BE821719A (fr) 1975-04-30
JPS6033834B2 (ja) 1985-08-05
YU261974A (en) 1982-06-18
NL180979C (nl) 1987-06-01
AT337178B (de) 1977-06-10
ES431675A1 (es) 1977-04-16
SE7413832L (pl) 1975-05-06
DE2451932A1 (de) 1975-05-07
AU7329074A (en) 1976-03-18
DE2451932C2 (de) 1983-09-29
SU515457A3 (ru) 1976-05-25
CH611290A5 (pl) 1979-05-31
PL100502B1 (pl) 1978-10-31
DD116229A5 (pl) 1975-11-12
JPS5082073A (pl) 1975-07-03
US3928598A (en) 1975-12-23
GB1487636A (en) 1977-10-05
IE40025L (en) 1975-05-05
DK136718C (pl) 1978-04-24
HU169192B (pl) 1976-10-28
NL7414437A (nl) 1975-05-07
CS193506B2 (en) 1979-10-31
PH10476A (en) 1977-05-11
FR2249663B1 (pl) 1978-03-24
ATA886274A (de) 1976-10-15
DK573174A (pl) 1975-07-07
BG25995A3 (pl) 1979-01-12
SE415761B (sv) 1980-10-27
NL180979B (nl) 1987-01-02
IL45662A (en) 1978-03-10

Similar Documents

Publication Publication Date Title
PL94965B1 (pl)
GB1491930A (en) Dyeing compositions containing quaternary azo dyestuffs derived from 2-aminopyridine
KR840004425A (ko) N-알킬-노스코핀의 제조방법
GB1402047A (en) Aqueous ink for use in the ink jet process
IE46278L (en) Tri-phenyl-substituted-piperazine derivatives
IE41528L (en) Furfuryl-benzomorphane derivatives.
KR870002056A (ko) 치환된 프로파르길옥시아세토니트릴 유도체의 제조 방법
ES470787A1 (es) Procedimiento para preparar derivados de benzoquinolicina
EP0312352A3 (en) Cyclodextrin derivatives and processes for preparing same
GB1512410A (en) Metal complexes of bishydrazides and processes for the production thereof
JPS5692116A (en) Settling agent for red mud
GB1436825A (en) Corrosion-inhibiting composition
KR920009931A (ko) 반응성 염료
GB1350297A (en) Water miscible stock solutions of chromium complex azo dyes containing sulphonic acid groups
EP0191375A3 (en) 7-n-aminomethylenemitomycin derivatives, process for production thereof and anti-tumor composition
IE44294L (en) 5-thiazole methane amine derivatives
KR920021667A (ko) 반응성 염료
JPS51118771A (en) Method for preparing carbostyryl derivatives
GB1377731A (en) Use of solid carrier for dyeing hydrophobic fibres
GB1517979A (en) Molybdate orange pigment
IE40676L (en) Dibenzo (thiepino or oxepino-) -pyrrole compounds
KR870001266A (ko) 수용성 모노아조 화합물의 제조방법
JPS5547696A (en) Platinum-prednin complex and its preparation
GB1456067A (en) Water-insuluble naphtholactam dyestuffs
IE38398B1 (en) Process for the manufacture of 9,10-seco oestrane derivatives